Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Accumulated Depreciation (2023 - 2025)

Historic Accumulated Depreciation for 60 Degrees Pharmaceuticals (SXTP) over the last 3 years, with Q3 2025 value amounting to $175685.0.

  • 60 Degrees Pharmaceuticals' Accumulated Depreciation rose 2201.7% to $175685.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $175685.0, marking a year-over-year increase of 2201.7%. This contributed to the annual value of $149433.0 for FY2024, which is 92.46% up from last year.
  • According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Accumulated Depreciation is $175685.0, which was up 2201.7% from $163460.0 recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Accumulated Depreciation registered a high of $175685.0 during Q3 2025, and its lowest value of $139650.0 during Q2 2024.
  • For the 3-year period, 60 Degrees Pharmaceuticals' Accumulated Depreciation averaged around $152871.4, with its median value being $148952.0 (2024).
  • In the last 5 years, 60 Degrees Pharmaceuticals' Accumulated Depreciation soared by 92.46% in 2024 and then soared by 2201.7% in 2025.
  • Over the past 3 years, 60 Degrees Pharmaceuticals' Accumulated Depreciation (Quarter) stood at $148064.0 in 2023, then rose by 0.92% to $149433.0 in 2024, then grew by 17.57% to $175685.0 in 2025.
  • Its last three reported values are $175685.0 in Q3 2025, $163460.0 for Q2 2025, and $154224.0 during Q1 2025.